Core Insights - Cuprina Holdings has secured exclusive licensing rights for Southeast Asia's first medical waste recycling technology, developed under the oversight of UNIDO and GEF, aimed at improving environmental management in the region [1][2][4] - The new technology utilizes advanced high-temperature steam treatment to sterilize and recycle medical waste, particularly plastic materials, contrasting with traditional incineration methods that produce toxic emissions [3][4] - The company plans to establish Singapore as the first hub for this technology outside of China, targeting significant growth opportunities in Southeast Asia as governments tighten environmental regulations [5] Company Overview - Cuprina Holdings is a biomedical and biotechnology company focused on developing products for chronic wound management and the health and beauty sectors [7] - The company aims to lead the transition from incineration to sustainable waste management practices, enhancing public health and environmental protection while creating long-term shareholder value [7] Industry Context - The global medical waste management market was valued at USD 34.06 billion in 2023 and is projected to reach USD 59.42 billion by 2030, growing at an annual rate of 8%, with Asia-Pacific identified as the fastest-growing region [6]
Cuprina Secures Exclusive Rights to Southeast Asia’s First UNIDO/GEF- Demonstrated Medical Waste Recycling Technology